ArticleContrast media & molecular imaging2022
Automated Recognition of Cancer Tissues through Deep Learning Framework from the Photoacoustic Specimen.
Article in Contrast media & molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Vascular graph network for ovarian lesion classification using optical-resolution photoacoustic microscopy.Photoacoustics · 2026Article
- Utilization of Bioinorganic Nanodrugs and Nanomaterials for the Control of Infectious Diseases Using Deep Learning.BioMed research international · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The fast advancement of biomedical research technology has expanded and enhanced the spectrum of diagnostic instruments. Various research groups have found optical imaging, ultrasonic imaging, and magnetic resonance imaging to create multifunctional devices that are critical for biomedical activities. Multispectral photoacoustic imaging that integrates the ideas of optical and ultrasonic technologies is one of the most essential instruments. At the same time, early cancer identification is becoming increasingly important in order to minimize fatality. Deep learning (DL) techniques have recently advanced to the point where they can be used to diagnose and classify cancer using biological images. This paper describes a hybrid optimization method that combines in-depth transfer learning-based cancer detection with multispectral photoacoustic imaging. The goal of the PS-ACO-RNN approach is to use ultrasound images to detect and classify the presence of cancer. Bilateral filtration (BF) is often used as a noise removal approach in image processing. In addition, lightweight LEDNet models are used to separate the biological images. A feature extractor with particle swarm with ant colony optimization (PS-ACO) paradigm can also be used. Finally, biological images assign appropriate class labels using a recurrent neural network (RNN) model. The effectiveness of the PS-ACO-RNN technique is verified using a benchmark database, and test results show that the PS-ACO-RNN approach works better than current approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.